Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

CT scans underused for lung cancer screens

Pham DC et al. ASCO 2018. Abstract 6504.

Publish date:: May 29, 2018

Key clinical point: The rate of lung cancer screening among eligible patients is overall very low.

Major finding: Just 1.9% of estimated, eligible current and former heavy smokers in the United States underwent low-dose CT screening for lung cancer in 2016.

Study details: Nationwide, cross-sectional cohort study of screening among an estimated 7,612,975 eligible smokers.

Disclosures: Dr. Pham disclosed no relevant conflicts of interest. The study received grant funding from the Bristol-Myers Squibb Foundation.

Source: Pham DC et al. ASCO 2018. Abstract 6504.

Read the article.

Citation:

Pham DC et al. ASCO 2018. Abstract 6504.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Lung Cancer

Two different radiation boost strategies reduce local failures in NSCLC,

Rechallenge ‘reasonable’ for some with small-cell lung cancer,

Black patients with ES-SCLC get less chemo but have better survival,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Reduced cancer mortality with Medicaid expansion,